Pegcetacoplan: A New Opportunity for Complement Inhibition in PNH

被引：9
|
作者：
Weitz, Ilene Ceil [1 ]
机构：
[1] Keck USC Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90089 USA
来源：
JOURNAL OF BLOOD MEDICINE | 2023年 / 14卷
关键词：
PNH; complement inhibition; extravascular hemolysis; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; ECULIZUMAB; HEMOLYSIS;
D O I：
10.2147/JBM.S362220
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pegcetacoplan is the newest inhibitor of the complement system to be approved by the FDA and EMA for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). The cyclic peptide inhibitor of C3 was evaluated in several clinical trials in PHN leading to its approval. The focus of this paper will review the efficacy and safety of Pegcetacoplan (PEG), and considerations for use in patients with PNH.
引用
收藏
页码：239 / 245
页数：7
相关论文
共 50 条
  • [1] Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors
    Hillmen, Peter
    Horneff, Regina
    Yeh, Michael
    Kolev, Martin
    Deschatelets, Pascal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [2] PNH: Simultaneous Immunosuppression and complement Inhibition
    Krome, Susanne
    TRANSFUSIONSMEDIZIN, 2023, 13 (01) : 14 - 14
  • [3] Pegcetacoplan versus Eculizumab in PNH REPLY
    Hillmen, Peter
    Risitano, Antonio M.
    de latour, Regis Peffault
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (18): : 1725 - 1726
  • [4] Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond
    de Latour, Regis Peffault
    Risitano, Antonio M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S3 - S4
  • [5] Pegcetacoplan Complement Inhibitor with a new Action Mechanism
    Scheikholeslami, Jubin
    Kolbrink, Benedikt
    NEPHROLOGE, 2022, 17 (03): : 189 - 190
  • [6] Pegcetacoplan Complement inhibitor with a new mechanism of action
    Scheikholeslami, Jubin
    Kolbrink, Benedikt
    NEPHROLOGIE, 2022, 17 (03): : 189 - 190
  • [7] Breakthrough Hemolysis in PNH with Proximal or Terminal Complement Inhibition
    Notaro, Rosario
    Luzzatto, Lucio
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02): : 160 - 166
  • [8] Efficacy of complement inhibition with pegcetacoplan in children with C3 glomerulopathy
    Mancuso, Maria Cristina
    Cugno, Massimo
    Griffini, Samantha
    Grovetti, Elena
    Nittoli, Teresa
    Mastrangelo, Antonio
    Tedesco, Francesco
    Montini, Giovanni
    Ardissino, Gianluigi
    PEDIATRIC NEPHROLOGY, 2025, : 1959 - 1963
  • [9] Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond
    Gavriilaki, Eleni
    de latour, Egis Peffault
    Risitano, Antonio Maria
    BLOOD, 2022, 139 (25) : 3571 - 3582
  • [10] Pegcetacoplan as an effective treatment option for previously treated PNH patients
    Brudler, Olaf
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (09)
12345